Delivery Order SPE2DB24D8001-SPE2DB25FKZTH
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,987.39, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 2, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $3,707.66 and a period of performance through February 24, 2025. The contract is for the delivery of pharmaceutical products, including ZEPBOUND 15 MG/0.5 ML PEN 0.5ML, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a Firm Fixed Price pricing type, a ceiling value of $1,665.49, and a period of performance through February 19, 2025. This Delivery Order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This federal contract award, valued at $1,705.26, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order awarded under DLA's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 that enables Dakota Drug, Inc. to provide a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,223.92, is for the delivery of ZEPBOUND 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract is a firm fixed-price, non-set-aside award with a performance period through April 4, 2025. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant Indefinite Delivery Contract...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The $3,074.85 firm fixed-price delivery order is for the supply of ZEPBOUND 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of May 16, 2025. Dakota Drug, Inc. also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, that is part of the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $4,704.09, is for the delivery of pharmaceutical products, specifically the drug Zepbound 5 mg/0.5 ml pen. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZNH, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,828.26 firm fixed-price delivery order is for the supply of 4567886888 ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTTS, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,848.11 and a performance period extending through February 5, 2025. This contract is not set aside and is a Firm Fixed Price Delivery Order. Dakota Drug, Inc. is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of Mounjaro 10 mg/0.5 ml pens, a pharmaceutical product. The contract has a firm fixed price of $2,178.74 and a completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Dakota Drug, Inc. holds with the DLA, valued at $999,999,999.00,...